AIIMS Delhi to conduct Phase 2, 3 clinical trials of Bharat Biotech's nasal vaccine soon: Sources

The All India Institute Of Medical Sciences (AIIMS) here will be starting Phase 2/3 trials of Hyderabad-based Covid-19 vaccine manufacturer Bharat Biotech's nasal vaccine soon, sources informed on Wednesday. Amid ongoing research in many countries to develop nasal spray to help prevent Covid-19, Bharat Biotech's intranasal vaccine received regulatory approval for second Phase trials in August.

from https://ift.tt/3zUUuV3
via IFTTT